KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1

Historical Holders from Q3 2024 to Q3 2025

Type / Class
Debt / NOTE 6.000% 5/1
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
102,115,871
Holdings value
$79,947,428
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1

Period Principal Value Change Price Investors
2025 Q3 102,115,871 $79,947,428 $0.7354 4
2025 Q2 102,115,871 $79,512,797 +$79,512,797 $0.7414 4
2024 Q4 0 $0 -$5,943,570 0
2024 Q3 8,871 $5,943,570 +$5,943,570 $670 1